Thomas Lyons (“T.J.”) has over 25 years of Commercial, Strategic and Transactional experience spanning various operating, consulting, and advisory roles primarily within the Life Sciences industry.

Prior to joining Marinus, Mr. Lyons was a Managing Partner at Fidem Capital, a boutique financial advisory firm focused on Mergers & Acquisitions, Equity Financings, and Corporate Development for Health Care and Technology companies. Previously, he held Corporate & Business Development positions at Oscient Pharmaceuticals and Cempra Pharmaceuticals as well as a wide range of commercial roles of increasing responsibility at both Abbott Laboratories and Cephalon, Inc. He has also been a Managing Partner of Vector Advisory, a consultancy concentrating on Corporate Development and Strategic Advisory initiatives to Life Science and Healthcare companies.

Throughout his various roles, Mr. Lyons has been involved with the launch of a number of proprietary biopharmaceutical products and executed a broad range of transactions including product in-/out-licensing, M&A, asset acquisitions/divestitures/spin-outs, financings, co-promotions, joint ventures, and strategic alliances for both private and public entities ranging from start-ups to Fortune 50 international corporations. He joined Marinus in his current role in January 2018. Mr. Lyons holds a B.S. in Business Administration & Marketing from Boston College and an M.B.A in Finance & Entrepreneurship from Babson College. He has held FINRA Series 7, 63 & 79 licenses for securities transactions and investment banking.